01 1Zhejiang Syncozymes Bio-pharmaceutical Co., Ltd
01 1Atogepant
01 1China
NDC Package Code : 84633-1001
Start Marketing Date : 2024-08-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
88
PharmaCompass offers a list of Atogepant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atogepant manufacturer or Atogepant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atogepant manufacturer or Atogepant supplier.
PharmaCompass also assists you with knowing the Atogepant API Price utilized in the formulation of products. Atogepant API Price is not always fixed or binding as the Atogepant Price is obtained through a variety of data sources. The Atogepant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Atogepant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atogepant, including repackagers and relabelers. The FDA regulates Atogepant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atogepant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atogepant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atogepant supplier is an individual or a company that provides Atogepant active pharmaceutical ingredient (API) or Atogepant finished formulations upon request. The Atogepant suppliers may include Atogepant API manufacturers, exporters, distributors and traders.
click here to find a list of Atogepant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atogepant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atogepant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atogepant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atogepant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atogepant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atogepant suppliers with NDC on PharmaCompass.
